Innovate Biopharmaceuticals to present progress towards phase 3 celiac disease trials at BIO 2017 Convention
June 06, 2017 08:07 ET
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., June 06, 2017 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, a leader in developing innovative therapies for autoimmune and inflammatory diseases, will present on its phase 3 drug...
Vital Therapies Provides Corporate Update
January 09, 2017 08:00 ET
|
Vital Therapies, Inc.
SAN DIEGO, Jan. 09, 2017 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver...